| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |